These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26493254)

  • 41. Iloprost treatment on top of infrapopliteal angioplasty accelerates wound healing in critical leg ischemia.
    K Ay N; Inan B
    Vascular; 2020 Feb; 28(1):74-80. PubMed ID: 31357910
    [No Abstract]   [Full Text] [Related]  

  • 42. Drug-eluting balloons in below the knee treatment.
    VAN DEN Berg JC
    J Cardiovasc Surg (Torino); 2016 Dec; 57(6):811-816. PubMed ID: 27654100
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of the Biodegradable Igaki-Tamai Scaffold After Drug-Eluting Balloon Treatment of De Novo Superficial Femoral Artery Lesions: The GAIA-DEB Study.
    Werner M; Schmidt A; Scheinert S; Banning-Eichenseer U; Ulrich M; Bausback Y; Steiner S; Scheinert D
    J Endovasc Ther; 2016 Feb; 23(1):92-7. PubMed ID: 26620399
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions.
    Zeller T; Rastan A; Macharzina R; Tepe G; Kaspar M; Chavarria J; Beschorner U; Schwarzwälder U; Schwarz T; Noory E
    J Endovasc Ther; 2014 Jun; 21(3):359-68. PubMed ID: 24915582
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aneurysmal Degeneration After Paclitaxel-Eluting Balloon Angioplasty.
    Chen W; Dyniewski B; Bobka T; Kraemer C; Tan TW; Zhou W
    Vasc Endovascular Surg; 2021 May; 55(4):410-414. PubMed ID: 33323050
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cost-effectiveness analysis of paclitaxel-coated balloons for endovascular therapy of femoropopliteal arterial obstructions.
    Diehm N; Schneider H
    J Endovasc Ther; 2013 Dec; 20(6):819-25. PubMed ID: 24325699
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Drug-Eluting Balloon Therapy for Femoropopliteal Occlusive Disease: Predictors of Outcome With a Special Emphasis on Calcium.
    Tepe G; Beschorner U; Ruether C; Fischer I; Pfaffinger P; Noory E; Zeller T
    J Endovasc Ther; 2015 Oct; 22(5):727-33. PubMed ID: 26250747
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stellarex Drug-Coated Balloon for Treatment of Femoropopliteal Disease: Twelve-Month Outcomes From the Randomized ILLUMENATE Pivotal and Pharmacokinetic Studies.
    Krishnan P; Faries P; Niazi K; Jain A; Sachar R; Bachinsky WB; Cardenas J; Werner M; Brodmann M; Mustapha JA; Mena-Hurtado C; Jaff MR; Holden AH; Lyden SP
    Circulation; 2017 Sep; 136(12):1102-1113. PubMed ID: 28729250
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug-Eluting vs Standard Balloon Angioplasty for Iliac Stent Restenosis: Midterm Results.
    Stahlhoff S; Donas KP; Torsello G; Osada N; Herten M
    J Endovasc Ther; 2015 Jun; 22(3):314-8. PubMed ID: 25991767
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Paclitaxel-coated versus plain old balloon angioplasty for the treatment of infrainguinal arterial disease in diabetic patients: the Belgian diabetic IN.PACT Trial.
    Debing E; Aerden D; Vanhulle A; Gallala S; von Kemp K;
    J Cardiovasc Surg (Torino); 2017 Aug; 58(4):528-534. PubMed ID: 27727202
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Commentary: drug-coated balloon angioplasty to improve carotid stenting outcomes after postendarterectomy restenosis: fad or an answer to the problem of recurrent restenosis?
    Del Giudice C; Pellerin O; Gandini R; Sapoval M
    J Endovasc Ther; 2015 Apr; 22(2):217-9. PubMed ID: 25809365
    [No Abstract]   [Full Text] [Related]  

  • 52. One-Year Outcomes of the Paclitaxel-Eluting, Self-Expanding Stentys Stent System in the Treatment of Infrapopliteal Lesions in Patients With Critical Limb Ischemia.
    Bosiers M; Callaert J; Keirse K; Hendriks JMH; Peeters P; Verbist J; Maene L; Beelen R; Deloose K
    J Endovasc Ther; 2017 Jun; 24(3):311-316. PubMed ID: 28351310
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Commentary: laser debulking and drug-eluting balloons for in-stent restenosis: a light at the end of the tunnel?
    van den Berg JC
    J Endovasc Ther; 2013 Dec; 20(6):815-8. PubMed ID: 24325698
    [No Abstract]   [Full Text] [Related]  

  • 54. Endovascular Treatment of Claudication due to Isolated Internal Iliac Artery Occlusive Disease.
    Brewer MB; Lau DL; Lee JT
    Ann Vasc Surg; 2019 May; 57():48.e1-48.e5. PubMed ID: 30114502
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Drug-eluting balloons: are they the magic bullet?
    Varcoe RL
    J Endovasc Ther; 2012 Oct; 19(5):581-4. PubMed ID: 23046321
    [No Abstract]   [Full Text] [Related]  

  • 56. Update on PADI trial: percutaneous transluminal angioplasty and drug-eluting stents for infrapopliteal lesions in critical limb ischemia.
    Martens JM; Knippenberg B; Vos JA; de Vries JP; Hansen BE; van Overhagen H;
    J Vasc Surg; 2009 Sep; 50(3):687-9. PubMed ID: 19700099
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bioresorbable Everolimus-Eluting Vascular Scaffold for Patients With Peripheral Artery Disease (ESPRIT I): 2-Year Clinical and Imaging Results.
    Lammer J; Bosiers M; Deloose K; Schmidt A; Zeller T; Wolf F; Lansink W; Sauguet A; Vermassen F; Lauwers G; Scheinert D; Popma JJ; McGreevy R; Rapoza R; Schwartz LB; Jaff MR
    JACC Cardiovasc Interv; 2016 Jun; 9(11):1178-87. PubMed ID: 27282601
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug-eluting balloons: are these failed solutions for the treatment of below-the-knee peripheral artery disease?
    Graziani L; Jaff MR
    Ann Vasc Surg; 2014 May; 28(4):1078-9. PubMed ID: 24530717
    [No Abstract]   [Full Text] [Related]  

  • 59. Paclitaxel-releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve-month results from the BIOLUX P-I randomized trial.
    Scheinert D; Schulte KL; Zeller T; Lammer J; Tepe G
    J Endovasc Ther; 2015 Feb; 22(1):14-21. PubMed ID: 25775674
    [TBL] [Abstract][Full Text] [Related]  

  • 60. IN.PACT™ Admiral™ drug-coated balloon: Durable, consistent and safe treatment for femoropopliteal peripheral artery disease.
    Peterson S; Hasenbank M; Silvestro C; Raina S
    Adv Drug Deliv Rev; 2017 Mar; 112():69-77. PubMed ID: 27771367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.